Novartis reported 37.24B in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Abbvie ABBV:US $ 26509M 1419M
Alcon AG ALC:SW 4.89B 498M
Amgen AMGN:US $ 18520M 865M
Artemis Alpha ATS:LN 10.02M 2.53M
AstraZeneca AZN:LN 22.65B 3.6B
Bayer BAYN:GR 38.25B 5.67B
Biogen BIIB:US $ 7915.9M 59.4M
Bristol Myers Squibb BMY:US $ 30121M 3141M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Fresenius FRE:GR € 18002M 541M
Fresenius Medical Care FME:GR € 8039.39M 72.15M
Galapagos GLPG:NA 4.75B 111.15M
Genmab GEN:DC 23.18B 439M
Gilead Sciences GILD:US $ 12629M 2143M
GlaxoSmithKline GSK:LN 28.99B 10.31B
GRIFOLS GRF:SM € 3239.5M 153.93M
H. Lundbeck A/S LUN:DC 9.04B 432M
Hikma Pharmaceutical HIK:LN 2.09B 139M
Johnson & Johnson JNJ:US $ 60424M 555M
Lonza Group LONN:SW 5.96B 925M
Merck MRK:GR € 11085M 103M
Merk MRK:US $ 31184M 918M
Novartis NOVN:VX 37.24B 8.48B
Novartis NVS:US $ 37236M 8482M
Orion ORNBV:FH 745.6M 55.3M
Pfizer PFE:US $ 54420M 5273M
Recordati REC:IM 961.62M 111.52M
Regeneron Pharmaceuticals REGN:US $ 14306M 291.1M